We recently showed that the inhibition of FASN activity with orlistat significantly impaired lipid synthesis, reduced proliferation and promoted apoptosis in the mouse metastatic melanoma cell line B16-F10 [46], [47]; additionally, similar treatment reduced experimental metastases and angiogenesis in B16-F10 melanomas [48]. This evidence concerns the gene FASN and melanoma.